Current status of signal transduction modulators in the treatment of gynecologic malignancies

Current Treatment Options in Oncology
Shay Ashouri, Agustin Garcia

Abstract

The introduction of platinum and paclitaxel had a pronounced effect in the prognosis and management of gynecological tumors. Preliminary results suggest that the use of signal transduction modulators, particularly inhibitors of angiogenesis has significant activity in recurrent ovarian cancer. Monoclonal antibodies against VEGF, such as bevacizumab, can be considered in the treatment of recurrent disease. Currently the role of bevacizumab as frontline therapy, in combination with cytotoxic chemotherapy, is being investigated in randomized phase III studies. It is expected that other signal transduction modulators will also have substantial activity in gynecological tumors.

References

Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BaselgaL Norton
Jul 1, 1996·The Netherlands Journal of Medicine·H H LichtenbeldH F Hillen
Oct 10, 1997·American Journal of Obstetrics and Gynecology·O AbulafiaD M Sherer
Apr 1, 1998·Journal of the National Cancer Institute·J YonedaI J Fidler
Dec 2, 1999·Nature Medicine·N Ferrara, K Alitalo
Jan 27, 2000·Cell·T Hunter
Feb 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BaselgaJ Mendelsohn
Mar 25, 2000·Journal of Cellular Biochemistry·M CampiglioA Ullrich
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
May 15, 2001·American Journal of Physiology. Cell Physiology·N Ferrara
May 18, 2001·Nature·P Blume-Jensen, T Hunter
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jocelyn HolashJohn S Rudge
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold F Dvorak
Jun 5, 2003·Nature Reviews. Cancer·Gabriele Bergers, Laura E Benjamin
Jun 12, 2003·British Journal of Cancer·H WildiersA T van Oosterom
Aug 7, 2003·Current Opinion in Pharmacology·Shile Huang, Peter J Houghton
Mar 31, 2004·Seminars in Oncology·Mitchell E GrossDavid B Agus
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Jul 23, 2004·The New England Journal of Medicine·David CunninghamEric Van Cutsem
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jakob DupontSteven L Soignet
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M R RaspolliniG L Taddei
Dec 14, 2004·The New England Journal of Medicine·Stephen A Cannistra
Dec 30, 2004·Nature Genetics·Ken InokiKun-Liang Guan
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Grace K DyAlex A Adjei
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Sep 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C AghajanianD R Spriggs
Sep 10, 2005·Cancer Immunology, Immunotherapy : CII·Camellia W AdamsMark X Sliwkowski
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Muralidhar BeeramEric K Rowinsky
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A N GordonE Barrett
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Limin HuRobert B Jaffe
Oct 8, 2005·Angiogenesis·S RamakrishnanM Geller
Mar 7, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A P G CrijnsE G E de Vries

❮ Previous
Next ❯

Citations

Jul 18, 2009·Annals of Diagnostic Pathology·Danielle WestfallElvio G Silva
Oct 29, 2008·Reproduction in Domestic Animals = Zuchthygiene·R Payan-Carreira, M Quaresma

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
A García-VelascoH Cortés-Funes
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Robert A Burger
© 2021 Meta ULC. All rights reserved